Skip to main content
. Author manuscript; available in PMC: 2012 May 24.
Published in final edited form as: Transpl Int. 2012 Mar;25(3):323–327. doi: 10.1111/j.1432-2277.2012.01428.x

Figure 1.

Figure 1

Hazard ratio for hemoglobin variability defined by moving standard deviation (SD) for (a) mortality and (b) functional graft survival. The Cox regression with restricted cubic splines was adjusted for hemoglobin and ESA therapy.